The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation

Abstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucida...

Full description

Bibliographic Details
Main Authors: Jie Zhou, Danni Ye, Siyao Zhang, Jiawei Ding, Tao Zhang, Zheng Chen, Fangshen Xu, Shenli Ren, Zhenhua Hu
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-024-03161-7
_version_ 1827327285994192896
author Jie Zhou
Danni Ye
Siyao Zhang
Jiawei Ding
Tao Zhang
Zheng Chen
Fangshen Xu
Shenli Ren
Zhenhua Hu
author_facet Jie Zhou
Danni Ye
Siyao Zhang
Jiawei Ding
Tao Zhang
Zheng Chen
Fangshen Xu
Shenli Ren
Zhenhua Hu
author_sort Jie Zhou
collection DOAJ
description Abstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucidated. We aimed to investigate the association between pre-transplant KPS score and long-term outcomes in HCC patients listed for liver transplantation. Methods Adult HCC candidates listed on the Scientific Registry of Transplant Recipients (SRTR) database from January 1, 2011 to December 31, 2017 were grouped into group I (KPS 80–100%, n = 8,379), group II (KPS 50–70%, n = 8,091), and group III (KPS 10–40%, n = 1,256) based on percentage KPS score at listing. Survival was compared and multivariable analysis was performed to identify independent predictors. Results Patients with low KPS score had a higher risk of removal from the waiting list. The 5-year intent-to-treat survival was 57.7% in group I, 53.2% in group II and 46.7% in group III (P < 0.001). The corresponding overall survival was 77.6%, 73.7% and 66.3% in three groups, respectively (P < 0.001). Multivariable analysis demonstrated that KPS was an independent predictor of intent-to-treat survival (P < 0.001, reference group I; HR 1.19 [95%CI 1.07–1.31] for group II, P = 0.001; HR 1.63 [95%CI 1.34–1.99] for group III, P < 0.001) and overall survival(P < 0.001, reference group I; HR 1.16 [95%CI 1.05–1.28] for group II, P = 0.004; HR 1.53 [95%CI 1.26–1.87] for group III, P < 0.001). The cumulative 5-year recurrence rates was higher in group III patients (7.4%), compared with 5.2% in group I and 5.5% in group II (P = 0.037). However, this was not significant in the competing regression analysis. Conclusions Low pre-transplant KPS score is associated with inferior long-term survival in liver transplant HCC patients, but is not significantly associated with post-transplant tumor recurrence.
first_indexed 2024-03-07T14:58:59Z
format Article
id doaj.art-ed6cc8bd435d4965bb9eab345295af47
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-03-07T14:58:59Z
publishDate 2024-02-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-ed6cc8bd435d4965bb9eab345295af472024-03-05T19:18:11ZengBMCBMC Gastroenterology1471-230X2024-02-012411910.1186/s12876-024-03161-7The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantationJie Zhou0Danni Ye1Siyao Zhang2Jiawei Ding3Tao Zhang4Zheng Chen5Fangshen Xu6Shenli Ren7Zhenhua Hu8Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityAbstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucidated. We aimed to investigate the association between pre-transplant KPS score and long-term outcomes in HCC patients listed for liver transplantation. Methods Adult HCC candidates listed on the Scientific Registry of Transplant Recipients (SRTR) database from January 1, 2011 to December 31, 2017 were grouped into group I (KPS 80–100%, n = 8,379), group II (KPS 50–70%, n = 8,091), and group III (KPS 10–40%, n = 1,256) based on percentage KPS score at listing. Survival was compared and multivariable analysis was performed to identify independent predictors. Results Patients with low KPS score had a higher risk of removal from the waiting list. The 5-year intent-to-treat survival was 57.7% in group I, 53.2% in group II and 46.7% in group III (P < 0.001). The corresponding overall survival was 77.6%, 73.7% and 66.3% in three groups, respectively (P < 0.001). Multivariable analysis demonstrated that KPS was an independent predictor of intent-to-treat survival (P < 0.001, reference group I; HR 1.19 [95%CI 1.07–1.31] for group II, P = 0.001; HR 1.63 [95%CI 1.34–1.99] for group III, P < 0.001) and overall survival(P < 0.001, reference group I; HR 1.16 [95%CI 1.05–1.28] for group II, P = 0.004; HR 1.53 [95%CI 1.26–1.87] for group III, P < 0.001). The cumulative 5-year recurrence rates was higher in group III patients (7.4%), compared with 5.2% in group I and 5.5% in group II (P = 0.037). However, this was not significant in the competing regression analysis. Conclusions Low pre-transplant KPS score is associated with inferior long-term survival in liver transplant HCC patients, but is not significantly associated with post-transplant tumor recurrence.https://doi.org/10.1186/s12876-024-03161-7Liver transplantationHepatocellular carcinomaKarnofsky Performance Status scaleWaiting listIntent-to-treat survivalTumor recurrence
spellingShingle Jie Zhou
Danni Ye
Siyao Zhang
Jiawei Ding
Tao Zhang
Zheng Chen
Fangshen Xu
Shenli Ren
Zhenhua Hu
The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
BMC Gastroenterology
Liver transplantation
Hepatocellular carcinoma
Karnofsky Performance Status scale
Waiting list
Intent-to-treat survival
Tumor recurrence
title The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
title_full The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
title_fullStr The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
title_full_unstemmed The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
title_short The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
title_sort impact of karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
topic Liver transplantation
Hepatocellular carcinoma
Karnofsky Performance Status scale
Waiting list
Intent-to-treat survival
Tumor recurrence
url https://doi.org/10.1186/s12876-024-03161-7
work_keys_str_mv AT jiezhou theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT danniye theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT siyaozhang theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT jiaweiding theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT taozhang theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT zhengchen theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT fangshenxu theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT shenliren theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT zhenhuahu theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT jiezhou impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT danniye impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT siyaozhang impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT jiaweiding impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT taozhang impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT zhengchen impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT fangshenxu impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT shenliren impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation
AT zhenhuahu impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation